Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank89
3Y CAGR+52.8%
5Y CAGR+20.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+52.8%/yr
Annual compound
5Y CAGR
+20.6%/yr
Recent acceleration
Percentile
P89
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.74M | -17.7% |
| 2024 | $9.41M | +137.6% |
| 2023 | $3.96M | +82.4% |
| 2022 | $2.17M | -49.4% |
| 2021 | $4.29M | +41.6% |
| 2020 | $3.03M | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | -100.0% |
| 2017 | $2000.00 | - |
| 2016 | $0.00 | - |